Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease

Barham K. Abu Dayyeh; Fateh Bazerbachi; Isabel Graupera; Andres Cardenas

ArticleOPEN ACCESS

Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease

Abu Dayyeh B
Bazerbachi F
Graupera I
et al.

Journal of Hepatology

DOI: 10.1016/j.jhep.2019.07.026

25Citations

31Readers

Get full text

Cite

CITATION STYLE

APA

Abu Dayyeh, B. K., Bazerbachi, F., Graupera, I., & Cardenas, A. (2019, December 1). Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease. Journal of Hepatology. Elsevier B.V. https://doi.org/10.1016/j.jhep.2019.07.026

Readers' Seniority

PhD / Post grad / Masters / Doc 8

47%

Researcher 7

41%

Professor / Associate Prof. 2

12%

Readers' Discipline

Medicine and Dentistry 18

82%

Nursing and Health Professions 2

Economics, Econometrics and Finance 1

Sports and Recreations 1

Article Metrics

Social Media

Shares, Likes & Comments: 46

View details >

Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease

Author supplied keywords

References Powered by Scopus

Mechanisms of NAFLD development and therapeutic strategies

Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis

Treatment of NAFLD with diet, physical activity and exercise

Cited by Powered by Scopus

Management of non-alcoholic fatty liver disease

Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis

Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers

Register to see more suggestions

Cite

Readers' Seniority

Readers' Discipline

Article Metrics